Understanding program sustainability through Benefit-to-WAC ratio
Benefit-to-WAC ratio is a pulse check on copay program sustainability, but only when paired with coverage rate and claim data. Here's how to read it right.
Program analysis, operating frameworks, and platform milestones from the InfinityRx team.
Benefit-to-WAC ratio is a pulse check on copay program sustainability, but only when paired with coverage rate and claim data. Here's how to read it right.
Join InfinityRx at the Patient Pathways Congress in Philadelphia, Nov 17-20, 2026, to discuss innovations in patient support and program optimization.
InfinityRx ranks No. 156 on the 2026 Inc. 5000 list, showcasing remarkable growth and innovation in claims adjudication for pharmaceutical manufacturers.
Pharmacy behavior is visible the moment a claim is adjudicated. Quarterly audits catch it weeks later, after the value has already leaked. Close the gap.
InfinityRx wins Gold at the 2026 American Business Awards® for Health and Pharmaceutical Services, its third straight year of Stevie® honors.
Discover how unifying pharmacy and medical benefits on one platform can reduce operational overhead and enhance efficiency for specialty brands.
Under-reimbursement is a gross-to-net leak most manufacturers never quantify. How it happens in claims adjudication and how to stop it.
InfinityRx celebrates its success at the 2026 TITAN Business Awards, winning four prestigious honors for its innovative patient support solutions.
InfinityRx CEO Greg Savino, PharmD, earns two Gold and one Silver leadership honors at the 2026 Noble Business Awards.
InfinityRx is named #2 fastest-growing company in the Northeast on the 2026 Inc. Regionals list, reflecting its growth since 2021.
Explore how rapid implementation of patient support programs can enhance GTN performance, protecting millions in revenue and adapting to payer behavior.
A closed-loop framework for gross-to-net program integrity: find anomalies, recover leaked funds, and prevent repeat losses.
Discover why copay maximizers are becoming a significant financial threat to manufacturers, outpacing accumulators and complicating claims detection.
How copay accumulators divert manufacturer dollars from patient support, and what manufacturers can do to protect their copay programs.
Patient support stacks often run five to seven vendors. How fragmentation adds hidden cost and inefficiency, and what consolidation recovers.
InfinityRx wins a Bronze Stevie® Award for Customer Service Success at the 2025 American Business Awards®, following its 2024 Gold.
InfinityRx wins Gold at the 2024 American Business Awards® for Technical Support Strategy & Implementation, recognizing its claims platform.
No articles match those filters. Try removing one.
Sign up for insights on dual-benefit adjudication, pharmacy infrastructure, and the trends shaping both.